76 results on '"Chen, Sai"'
Search Results
2. Phase 2, Open-Label Study of Ciltacabtagene Autoleucel, an Anti-BCMA CAR-T Cell Therapy, in Chinese Patients with Relapsed/Refractory Multiple Myeloma (CARTIFAN-1): 26-Month Median Follow-up
3. Functional, structural, and molecular characterizations of the leukemogenic driver MEF2D-HNRNPUL1 fusion
4. PLCG1 is required for AML1-ETO leukemia stem cell self-renewal
5. SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS
6. Differential Expression of CD49f Discriminates the Independently Emerged Hematopoietic Stem Cells and Erythroid-Biased Progenitors
7. Updated Phase 1 Results of a First-in-Human Open-Label Study of Lcar-B38M, a Structurally Differentiated Chimeric Antigen Receptor T (CAR-T) Cell Therapy Targeting B-Cell Maturation Antigen (Bcma)
8. Dynamic Analysis of Cytokine Profile for Cytokine Release Syndrome in Multiple Myeloma Patients after CAR-T Cell Therapy
9. Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet
10. Angiogenesis Induced By Aminoacyl-tRNA Synthetase Deficiency Is Dependent on Amino Acid Response (AAR) but Not Unfolded Protein Response (UPR) Pathways
11. The Three E Proteins Define a Heterogeneity of the AML1-ETO-Containing Transcription Factor Complex (AETFC) and Differentially Regulate t(8;21) Leukemogenesis
12. Knock-in of Dnmt3a R878H Recapitulates Human Acute Myeloid Leukemia Harboring DNMT3A Mutation and Is Highly Responsive to mTOR Inhibitor Rapamycin
13. Functional Study of Novel Gene Fusions and Patterns of Epigenetic Regulator Mutations in Adult and Childhood B-Cell Acute Lymphoblastic Leukemia
14. NPM1 Mutation Contributes to Hematological Dysfunction By Disrupting H3K79 Methylation
15. Palladin Plays an Important Role in Pulmonary Cellular Infiltration in Differentiation Syndrome
16. Exome Sequencing Identifies Somatic Mutations of DDX3X in Natural Killer/T-Cell Lymphoma
17. High IDH1 Expression Is Associated with a Poor Prognosis in Cytogenetically Normal Acute Myeloid Leukemia
18. Molecular Mechanisms Underlying the Synergism of Erib and Hht in Treating t(8;21) AML with C-KIT mutations
19. Genome-Wide Abnormality Patterns of B-Lineage Acute Lymphoblastic Leukemia in Adults in Comparison with Pediatric Cases
20. A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value
21. LICs Of APL-Like Leukemia Lead a Step-Wise and Divergent Differentiation Course
22. Human NUP98/Iqcg Fusion Gene Induced An Acute Myelomonocytic Leukemia In Mice
23. Viral Infection Sentinel Rig-I Maintains Hematopoietic Stem Cell Function Through Regulating DNA-Damage Response
24. Structural framework of c-Src activation by integrin β3
25. A Calmodulin Interacting Protein Iqcg Is Required for Definitive Hematopoiesis in Zebrafish
26. High Musashi-2 Expression Is an Unfavorable Prognostic Factor in Adult B-Cell Acute Lymphoblastic Leukemia.
27. Oral Realgar-Indigo Naturalis Formula Achieved Comparably High Rate of Remission and Survival to Intravenous Arsenic Trioxide As a Front-Line Treatment in Newly Diagnosed Acute Promyelocytic Leukemia: A Multi-Center Randomized Trial APL07
28. DNMT3A Mutation Leads to Hematopoietic Dysregulation.
29. Serum 2-Hydroxyglutarate Level Is a Prognostic Marker in Acute Myeloid Leukemia
30. Prognostic Significance of Minimal Residual Disease in Adult Patients with B-Lineage Acute Lymphoblastic Leukemia by 8-Color Flow Cytometry
31. Homoharringtonine-Based Induction Regimens for Patients with De Novo Acute Myeloid Leukemia: A Multicenter Randomized Controlled Phase 3 Trial
32. Mutation associations in RA-defiant APL
33. Functional features of RUNX1 mutants in acute transformation of chronic myeloid leukemia and their contribution to inducing murine full-blown leukemia
34. Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia
35. Dominant-negative C/ebpα and polycomb group protein Bmi1 extend short-lived hematopoietic stem/progenitor cell life span and induce lethal dyserythropoiesis
36. Sumoylation of CCAAT/enhancer–binding protein α promotes the biased primitive hematopoiesis of zebrafish
37. From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia
38. Arsenic Sulfide Binds c-CBL to Promote BCR-ABL Ubiquitination and Degradation In Chronic Myelogenous Leukemia.
39. PML/RARa Represses Transactivation of PSMB10 Via a PU.1-Dependent Manner In Acute Promyelocytic Leukemia
40. Protein Degradation and Resultant Hsp90 Dephosphorylation as An Alternative C-KIT Kinase Inhibition Strategy
41. Recurrent Mutations Found In Acute Monocytic Leukemia by Exomes Sequencing
42. An evolutionarily conserved PTEN-C/EBPα-CTNNA1 axis controls myeloid development and transformation
43. Cytogenetic and Molecular Features of 1331 Chinese Patients with Primary Acute Lymphoblastic Leukemia (ALL).
44. Coordination of Fenretinide-Induced Apoptosis by Stress-Responsive Regulators in Leukemia Cells
45. Front-Line Therapy with Arsenic Trioxide/All-Trans-Retinoic Acid Combination and Chemotherapy Improves Cure Rates in Newly Diagnosed Patients with Acute Promyelocytic Leukemia
46. Systems Understanding of Synergism Between As4S4 and Imatinib in Treating BCR/ABL Leukemia Model and in Attenuating BCR/ABL Oncoprotein as Well as Related Regulatory Networks
47. Rig-I Activates Expression of Interferon-Stimulated Genes (ISGs) and Inhibits the Proliferation of Acute Myeloid Leukemia Cells
48. A Novel Mechanism Underlying the Expression Regulation of An IFN-Inducible Gene RIG-G
49. PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor
50. Response: Multiple role of PRDM1β involvement in diffuse large B-cell lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.